Truist Financial Has Lowered Expectations for HCA Healthcare (NYSE:HCA) Stock Price

HCA Healthcare (NYSE:HCA) had its price objective lowered by Truist Financial from $430.00 to $390.00 in a research note issued to investors on Monday morning,Benzinga reports. Truist Financial currently has a buy rating on the stock.

A number of other equities analysts have also recently weighed in on the stock. Morgan Stanley decreased their price objective on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a research report on Tuesday, December 17th. Barclays dropped their price objective on HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating on the stock in a report on Friday, November 8th. Wells Fargo & Company lowered shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and dropped their price target for the stock from $400.00 to $320.00 in a research note on Monday, November 25th. Raymond James lowered shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. Finally, TD Cowen reduced their price target on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research report on Monday, October 28th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $385.27.

HCA Healthcare Trading Up 1.0 %

HCA opened at $311.19 on Monday. The firm has a market capitalization of $78.82 billion, a P/E ratio of 13.97, a P/E/G ratio of 1.21 and a beta of 1.64. The firm’s 50 day moving average is $323.68 and its 200-day moving average is $354.18. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. HCA Healthcare has a 52-week low of $276.50 and a 52-week high of $417.14.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 27th. Investors of record on Friday, December 13th were issued a $0.66 dividend. The ex-dividend date of this dividend was Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.85%. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.85%.

Insiders Place Their Bets

In other news, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the transaction, the insider now directly owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Phillip G. Billington sold 3,897 shares of the firm’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the transaction, the senior vice president now directly owns 52,702 shares in the company, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their position. The disclosure for this sale can be found here. 1.70% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of HCA. Savant Capital LLC boosted its holdings in HCA Healthcare by 68.6% during the second quarter. Savant Capital LLC now owns 3,454 shares of the company’s stock worth $1,110,000 after buying an additional 1,405 shares in the last quarter. Great Lakes Advisors LLC purchased a new stake in HCA Healthcare in the 2nd quarter worth about $7,790,000. Acadian Asset Management LLC increased its holdings in shares of HCA Healthcare by 108.2% in the 2nd quarter. Acadian Asset Management LLC now owns 7,021 shares of the company’s stock valued at $2,253,000 after purchasing an additional 3,649 shares during the period. Koss Olinger Consulting LLC acquired a new stake in shares of HCA Healthcare during the second quarter worth approximately $303,000. Finally, Ballentine Partners LLC increased its stake in HCA Healthcare by 3.3% in the 2nd quarter. Ballentine Partners LLC now owns 4,006 shares of the company’s stock valued at $1,287,000 after buying an additional 127 shares during the period. 62.73% of the stock is owned by institutional investors and hedge funds.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.